In the 2016 CNS WHO criteria, the IDH1 genotypes and status of 1p and 19q codeletion were absorbed into the classification of gliomas, and therefore, we investigated the distribution of TAF12 expression in the above molecular subclasses of gliomas. Here, TAF12 is linked to central nervous system cancer.